Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted exosome‐encapsulated erastin induced ferroptosis in triple negative breast cancer cells
Mengyu Yu, Chengcheng Gai, Zihaoran Li, et al.
Cancer Science (2019) Vol. 110, Iss. 10, pp. 3173-3182
Open Access | Times Cited: 286

Showing 1-25 of 286 citing articles:

Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy
Boyi Niu, Kaixin Liao, Yixian Zhou, et al.
Biomaterials (2021) Vol. 277, pp. 121110-121110
Closed Access | Times Cited: 760
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 499
Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research
Xuhui Tong, Rong Tang, Mingming Xiao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 490
Ferroptosis in cancer and cancer immunotherapy
Lei Zhao, Xiaoxue Zhou, Feng Xie, et al.
Cancer Communications (2022) Vol. 42, Iss. 2, pp. 88-116
Open Access | Times Cited: 415
Exosome engineering: Current progress in cargo loading and targeted delivery
Shengyang Fu, Yi Wang, Xiaohuan Xia, et al.
NanoImpact (2020) Vol. 20, pp. 100261-100261
Open Access | Times Cited: 334
<p>Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development</p>
Victor C. Kok, Cheng‐Chia Yu
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 8019-8036
Open Access | Times Cited: 315
Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells
Yahui Ding, Xiaoping Chen, Can Liu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 309
Ferroptosis in Cancer Cell Biology
Christina M. Bebber, Fabienne Müller, Laura Prieto Clemente, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 164-164
Open Access | Times Cited: 284
A Comprehensive Review on Factors Influences Biogenesis, Functions, Therapeutic and Clinical Implications of Exosomes
Sangiliyandi Gurunathan, Min-Hee Kang, Jin‐Hoi Kim
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 1281-1312
Open Access | Times Cited: 258
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Shumin Sun, Jie Shen, Jianwei Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 235
Emerging mechanisms and targeted therapy of ferroptosis in cancer
Haiyan Wang, Yan Cheng, Chao Mao, et al.
Molecular Therapy (2021) Vol. 29, Iss. 7, pp. 2185-2208
Open Access | Times Cited: 229
Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer
Sha Li, Yijing Wu, Fei Ding, et al.
Nanoscale (2020) Vol. 12, Iss. 19, pp. 10854-10862
Closed Access | Times Cited: 200
System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy
Feng‐Jiao Li, Hui‐Zhi Long, Ziwei Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 200
Designer Exosomes: A New Platform for Biotechnology Therapeutics
Davod Jafari, Samira Shajari, Rasool Jafari, et al.
BioDrugs (2020) Vol. 34, Iss. 5, pp. 567-586
Open Access | Times Cited: 193
The function and mechanism of ferroptosis in cancer
Ying Wang, Zihao Wei, Keran Pan, et al.
APOPTOSIS (2020) Vol. 25, Iss. 11-12, pp. 786-798
Closed Access | Times Cited: 189
Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy
Jianbing Du, Zhuo Wan, Cong Wang, et al.
Theranostics (2021) Vol. 11, Iss. 17, pp. 8185-8196
Open Access | Times Cited: 177
Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle
Xia Wang, Lü Tian, Jingyi Lu, et al.
Oncogenesis (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 157
Simvastatin induced ferroptosis for triple-negative breast cancer therapy
Xianxian Yao, Ruihong Xie, Yongbin Cao, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 152
Ferroptosis in Cancer Treatment: Another Way to Rome
Yinan Wu, Chengcheng Yu, Meng Luo, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 148
Targeting ferroptosis in breast cancer
Zhaoqing Li, Lini Chen, Cong Chen, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 147
Baicalin Inhibits Ferroptosis in Intracerebral Hemorrhage
Lining Duan, Ying Zhang, Yuna Yang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 108
New advances in exosome-based targeted drug delivery systems
Débora Ferreira, João Nuno Moreira, L. R. Rodrigues
Critical Reviews in Oncology/Hematology (2022) Vol. 172, pp. 103628-103628
Open Access | Times Cited: 103
Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies
Minru Liao, Rui Qin, Wei Huang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 97
Exosome-Derived lncRNA NEAT1 Exacerbates Sepsis-Associated Encephalopathy by Promoting Ferroptosis Through Regulating miR-9-5p/TFRC and GOT1 Axis
Xue‐biao Wei, Wenqiang Jiang, Juhao Zeng, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1954-1969
Open Access | Times Cited: 90
Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine
Xuan Wang, Peng Hua, Chengwei He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3567-3593
Open Access | Times Cited: 86
Page 1 - Next Page

Scroll to top